Current Research Projects

1. Captivate: The Chronic kidney disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect 

 2. ARCTIC: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination with Dapagliflozin on CKD Progression in Participants with CKD and High blood pressure (BaxDuo-Arctic)

3.BEAT-Calci: Better Evidence And Translation for Calciphylaxis

 

4. Renal Lifecycle- A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Severe Chronic Kidney Disease

5. Beyond: A Phase 3, Randomized, Double-blind, Placebo controlled Study of BION-1301 in Adults with IgA Nephropathy

6. Imagination: A Phase III, multicenter, randomized, double blind, placebo controlled study to evaluate the efficacy and safety of RO7434656, an antisense inhibitor of complement factor B, in patients with primary IgA nephropathy at risk of progression.

7. Visionary(OLE): A Phase 2/3, Multicenter, Open label Trial to Evaluate the Long term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy.

         8.. INCH-HD : The INCremental dialysis to improve Health outcomes in people starting Haemodialysis study: a randomised controlled trial. 

Please contact Saiyini Pirabhahar for further information about the above studies 9113 2484


 

Kidney Supportive Care Masterclass 2025

Thursday 31st July – Friday 1st August 2025 Contact: SESLHD-STG-KSCCNC@health.nsw.gov.au 9113 2854 Registration Program link to the KSC Masterclass recordings

Read more

30 Apr 2025

Private Health Funds are now offering Assisted Home Haemodialysis (AHHD) model of care to eligible memebers

Assisted Home Haemodialysis (AHHD) – to eligible members Private Health Funds include: NIB – including GU Health, Qantas, ING, Priceline,…

Read more

08 Jun 2023

Newly published article

Moral Distress and Moral Injury in Nephrology during the COVID – 19 Pandemic Ducharlet K, Trivedi M, Gelfand SL, Liew…

Read more

02 Aug 2021